2004, Number 2
<< Back Next >>
Med Sur 2004; 11 (2)
Heparin-associated thrombocytopenia
Contreras CNA, Robles-Landa LPA
Language: Spanish
References: 10
Page: 99-108
PDF size: 96.42 Kb.
ABSTRACT
Heparin-associated thrombocytopenia (HAT) occurs in 5-10% of patients treated with heparin and has two forms of presentation: the severe form is caused by the presence of heparin-dependent antibodies that produce platelet aggregation and possible thrombosis. HAT with thrombosis is rare (0.2-0.4%) but worsens the prognosis and may entail immediate discontinuation of heparin administration, treatment of complications, and the use of alternative therapy for anticoagulation.
Its diagnosis is based on clinical criteria and may be supported by laboratory tests for heparin-dependent antibodies.
REFERENCES
Hirsh J. Laboratory monitoring of low-molecular-weight heparin therapy. J Thromb Haemost 2004; 2(6): 1003.
Hirsh J, Heddle N, Kelton JG. Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med 2004; 164(4): 361-9.
Hirsh J. New anticoagulants. Am Heart J 2001; 142(2 Suppl): S3-8. Review.
Shuster TA, Silliman WR, Coats RD, Mureebe L, Silver D. Heparin-induced thrombocytopenia: twenty-nine years later. J Vasc Surg 2003; 38(6): 1316-22.
Bick RL, Frenkel EP. Clinical aspects of heparin-induced thrombocytopenia and thrombosis and other side effects of heparin therapy. Clin Appl Thromb Hemost 1999; Suppl 1: S7-15. Review.
Wallis DE, Quintos R, Wehrmacher W, Messmore H. Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia. Chest 1999; 16(5): 1333-8.
Calaitges JG, Liem TK, Spadone D, Nichols WK, Silver D. The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction. J Vasc Surg 1999; 29(5): 779-85; discussion 785-6.
Walenga JM, Bick RL. Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy. Med Clin North Am 1998; 82(3): 635-58. Review.
Wilde MI, Markham A. Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. Drugs 1997; 54(6): 903-24. Review.
Slaughter TF, Greenberg CS. Heparin-associated thrombocytopenia and thrombosis: implications for perioperative management. Anesthesiology 1997; 87(3): 667-75. Review.